About Tiger Biotherapeutics
Tiger Biotherapeutics is a private company based in Cranbury, New Jersey, incorporated in 2023 in Delaware. It has reported $20,000,230 raised in one offering on Form D since April 2023. Its chief executive is Jie Fan.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 23, 2023 | Apr 5, 2023 | $20,000,230of $22.0M target | 4 | $5.0M | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Tiger Biotherapeutics's Form D filed Apr 5, 2023.